Work This Way: A Labor & Employment Law Podcast - Episode 31: Trade Secrets and Protecting Confidential Information with Jennie Cluverius of Maynard Nexsen
Trade Secret Litigation: The Power of Protection
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the United States
The FBI on Economic Espionage
Partner Greg Rolen Discusses a Whistleblower Claim at Fremont Union School District’s Board Meeting
Don’t go too far when investigating trade secret misappropriation by an employee (Fairly Competing, Podcast Episode 17)
#WorkforceWednesday: Spilling Secrets: Employers - Train on Trade Secrets - Employment Law This Week®
Trade Secret Two-Step: Part 2
Trade Secret Two-Step: Part 1
Monthly Minute | Trade Secret Protection Best Practices–Exit Interviews
Nota Bene Episode 110: Mapping U.S. Domestic and Extraterritorial Trade Secret Protection and Enforcement with Robert Friedman
Pepe the Frog
JONES DAY PRESENTS®: Helping Clients with Trade Secret Protection
JONES DAY PRESENTS®: Trade Secret Enforcement in the United Kingdom
JONES DAY PRESENTS®: Trade Secret Enforcement in Spain
JONES DAY PRESENTS®: Trade Secret Enforcement in France
JONES DAY PRESENTS®: Trade Secret Enforcement in Taiwan
JONES DAY TALKS®: Women in IP: Protecting Trade Secrets in Remote-Work Situations
JONES DAY PRESENTS®: Trade Secret vs. Patent Litigation
U.S. International Trade Commission
Alvotech Holdings S.A. (“Alvotech”) has announced that they have settled all pending disputes between AbbVie and Alvotech related to AVT02 (100mg/mL), Alvotech’s high-concentration, citrate-free biosimilar candidate for...more
As noted in our December 21, 2021 post, Complainants AbbVie Inc., AbbVie Biotechnology Ltd. and AbbVie Operations Singapore Pte. Ltd. filed a complaint at the International Trade Commission against Respondents Alvotech hf.,...more
As we previously reported, in October 2018, Genentech brought claims against Taiwan-based biosimilar developer JHL Biotech, Inc. and individual defendants for trade secret misappropriation, computer fraud, breach of contract,...more
On October 25, 2018, the U.S. Attorney for the Northern District of California filed an indictment against four individuals (three of whom were former Genentech employees) alleging theft of trade secrets, computer fraud and...more
On May 10, 2017, Amgen filed a complaint in the District of Delaware asserting that, under section 35 U.S.C. § 271(e)(2)(C)(i) of the Biologics Price Competition and Innovation Act (“BPCIA”), Coherus infringed Amgen’s U.S....more